Sunday, August 14, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study describes the impact of COVID-19 pandemic on pediatric primary care mental health visits

by Medical Finance
in Coronavirus
New tool could help detect geographical hotspots for mental health problems caused by COVID
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A new study describes the impact of the COVID-19 pandemic on pediatric primary care mental health visits. Findings from the study will be presented during the Pediatric Academic Societies (PAS) 2022 Meeting, taking place April 21-25 in Denver.

Researchers with Boston Children’s Hospital found that visits to pediatric primary care offices for eating disorder and depressive and bipolar disorder began increasing significantly at the start of the pandemic period, whereas alcohol and substance use disorder visits immediately decreased in frequency and were less frequent over time.

These results reveal an increased burden of mental health care provision in the primary care office since the start of the pandemic and highlight the importance of screening for, provisionally diagnosing, and managing youth mental health conditions in primary care during periods of social isolation. Additional research is needed to further understand the impact of COVID-19 on youth mental health.

We aimed to describe the impact of the COVID-19 pandemic on pediatric mental health, specifically in terms of visits to primary care. We conducted an interrupted time series analysis of in-network visits among our large pediatric network in Massachusetts. Our findings reveal significant changes in the pattern of visits to primary care offices for mental health conditions in children and adolescents: most notably, striking increases in visits for eating disorders and mood disorders during the pandemic period. Conversely, visits for alcohol and substance use disorders declined during the pandemic period.”


Jane Bittner Gould, MPH, CPH, senior project manager at Pediatric Physicians’ Organization at Children’s

The self-reported mental health impacts of the COVID- 19 pandemic on adults include increased stress, anxiety, and depression. Research on the impact of pandemic-related social changes on the mental health of children and adolescents is more limited.

Ms. Gould will present “Impact of the Coronavirus Disease 2019 Pandemic on Mental Health Visits in Pediatric Primary Care” on Sunday, April 24 at 8:30 a.m. MDT. Reporters interested in an interview with Ms. Gould should contact [email protected]

The PAS Meeting connects thousands of pediatricians and other health care providers worldwide. For more information about the PAS Meeting, please visit www.pas-meeting.org.

Source:

Pediatric Academic Societies

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Families complain as states require covid testing for nursing home visits

At nursing homes, long waits for results render covid tests ‘useless’

by Medical Finance
August 14, 2022
0

More nursing homes are waiting longer for covid-19 test results for residents and staffers, according to federal data, making the...

Study: A model-based approach to improve intranasal sprays for respiratory viral infections. Image Credit: Dmitry Kovalchuk/Shutterstock

Novel approach to improve intranasal sprays used to treat respiratory viral infections

by Medical Finance
August 14, 2022
0

In a recent study posted to the medRxiv* preprint server, a team of researchers proposed a novel approach to...

Study: An intranasal lentiviral booster broadens immune recognition of SARS-CoV-2 variants and reinforces the waning mRNA vaccine-induced immunity that it targets to lung mucosa. Image Credit: Dmitry Kovalchuk/Shutterstock

Assessing an intranasal lentiviral booster against COVID-19 variants

by Medical Finance
August 14, 2022
0

Coronavirus disease 2019 (COVID-19) vaccines provide adaptive immunity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With the emergence...

Researchers identify gene expression signatures linked to suicide risk

Covid-19 patients are at increased risk of developing type 2 diabetes, study shows

by Medical Finance
August 14, 2022
0

People who have had Covid-19 are at increased risk of developing type 2 diabetes. This is the result of a...

New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

New nanoparticle SARS-CoV-2 vaccine shows stronger, broader, and more durable protection

by Medical Finance
August 14, 2022
0

The first generation of COVID-19 vaccines have been highly effective, but also have limitations: their efficacy can wane without a...

Surveying communities may be a useful tool for predicting COVID-19 case trajectories

Failure to invest in global health left the world ill-prepared for COVID-19, experts say

by Medical Finance
August 14, 2022
0

A key meeting of the WHO's executive board has spawned an upswell of calls to overhaul the UN agency's funding,...

Next Post
Study: In silico analysis of predicted differential MHC binding and CD8+ T-cell immune escape of SARS-CoV-2 B.1.1.529 variant mutant epitopes. Image Credit: Fit Ztudio/Shutterstock

Predicting immunity evasion of SARS-CoV-2 Omicron variant of concern

Study: Visible blue light inactivates SARS-CoV-2 variants and inhibits Delta replication in differentiated human airway epithelia. Image Credit: Nor Gal/Shutterstock

Researchers suggest that visible blue light is a safe and variant-agnostic therapy against SARS-CoV-2

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • HIV 620x480
    CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.
  • Study: SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against SARS-CoV-2 Delta and Omicron that can be predicted by anti-S antibody concentrations in serological assays. Image Credit: Studio Romantic/Shuttershock
    SARS-CoV-2 vaccination of convalescents suggested to boost neutralization capacity against variants
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply